SCHEMBL27865822

SCHEMBL27865822

COc1cc(-c2ccc3ncc(N4CCCCC4)nc3c2)ccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 4/20 0.48
▸ GAK O14976 3/20 0.45
▸ PDGFRB P09619 2/20 0.43
▸ PDGFRA P16234 2/20 0.43
▸ MET P08581 1/20 0.42
▸ MAPT P10636 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ PDE10A Q9Y233 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ PIK3CD O00329 2/20 0.40
▸ PIK3CG P48736 2/20 0.40
▸ HRH4 Q9H3N8 2/20 0.40
▸ PIK3CB P42338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1442090 0.91 PDGFRB (0.51) PIK3CAGAKPDGFRBPDGFRAMET
SCHEMBL1441906 0.89 GAK (0.56) PIK3CAGAKPDGFRBPDGFRAMET
SCHEMBL27865681 0.89 MTOR (0.49) PIK3CAGAKALDH1A1NPC1RAB9A
SCHEMBL27882019 0.86 PIK3CA (0.48) PIK3CAGAKPDGFRBPDGFRAMET
SCHEMBL1442748 0.85 PIK3CA (0.53) PIK3CAMAPTALDH1A1NPC1RAB9A
SCHEMBL27865701 0.84 MAP4K1 (0.52) PIK3CAMAPTALDH1A1NPC1RAB9A
SCHEMBL27882148 0.84 PIK3CA (0.51) PIK3CAGAKPDGFRBPDGFRAMET
SCHEMBL1442175 0.83 PIK3CA (0.50) PIK3CAGAKPDGFRBPDGFRAMET
SCHEMBL1442235 0.83 ALDH1A1 (0.47) PIK3CAMAPTALDH1A1NPC1RAB9A
SCHEMBL12811955 0.82 GAK (0.42) PIK3CAGAKMETMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596932-A Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors BAYER SCHERING PHARMA AG 2012-07-18 — — CN claimed
Send feedback